A recent study suggests that patients undergoing medication for opioid addiction may be spiking their urine tests with buprenorphine, the medication itself, going unnoticed during rapid tests. Researchers looked at over 500,000 urine test results that were taken from doctors’ offices and specialty facilities, finding that 8% of patients’ tests showed evidence of buprenorphine spiking. This could prove dangerous to a patient’s overdose risk and may indicate that they need a higher level of care. As such, doctors must assess the cause of these actions through responsible discussions with patients and refrain from punishing or judging them in any way.